Reasons for buying:
Buy PE was reasonable at 19.99 and above 10 years PE median of 15.44.
The 5-year earnings average is 37.23% and earnings increasing since 2012 except in 2018 and 2020.
Return on equity is good at 44.76% but the 5-year average is 25.33%.
The market cap of the company is ₹1,179.97 Cr.
The debt of the company is ₹16.45 Cr with ₹33.85 Cr in cash.
Buy date: 16-Mar-2022
Qty: 5 Buy Price: ₹1900 Buy EPS: 95.01 Buy PE: 19.99
I will stop buying when EPS drops from the current EPS but will add 10k if the price drops to ₹1710 and EPS remains the same.
NGL Fine-Chem is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates, and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. The company sells its products in India and also exports it to international countries, of which key revenue is derived from export sales.
No comments:
Post a Comment